From the earnings conference calls, shareholders in these marijuana enterprises learned about how well company management is meeting crucial performance goals. Here are the top three takeaways from pot stock earnings this week.
Marijuana firms are working diligently to improve production efficiency. The COVID-19 crisis might be a hindrance for many companies, but the pandemic is also uncovering crucial areas where these companies can cut fat out of the production process.
For example, HEXO saw the firm’s cost per gram to produce fall as payrolls dropped. Before the pandemic, the company may have been overstaffing growing or distribution operations.
The HEXO leadership acknowledged this unexpected impact of the COVID-19 restrictions in its conference call to shareholders. Therefore, the firm could potentially take this as a sign that they can create leaner operations.
Alternatively, HEXO may want to accept a higher cost per gram to produce in anticipation of soaring demand. There’s nothing wrong with maintaining flexible operations.
The pot stocks have been on spending sprees to increase the capacity to produce a slew of marijuana products. Expensive investments on unused capacity mean negative adjusted EBITDA and margins in the short-term.
As demand and sales soar, the cannabis enterprises are quickly beginning to reach capacity. At least, that’s the goal anyway. Neptune Wellness and HEXO expect that their past and current sales activities will help them reach profitability soon.
Successful sales and marketing campaigns are crucial for these pot stocks to utilize all available manufacturing capacity. By reaching maximum production volume, these marijuana enterprises will boost profit margins and achieve a positive adjusted EBITDA.
Expensive marketing and sales campaigns have been weighing down pot stock profitability. Further, the intense competition between legal and illegal distributors have pushed down prices. This war for market share will not end overnight.
HEXO has emerged as a winner in the battle over market share. Focusing on the supplier market, HEXO has garnered a 30% market share in its cannabis product segments.
Neptune Wellness did not give a precise estimate of the firm’s market share in its earnings conference call. Ambiguity aside, shareholders can use growing revenue as an imperfect proxy for market share approximations. Neptune’s CEO, Michael Cammarata, anticipates revenue growth of 300-400% in the first quarter of 2021 over the same quarter last year.
Neptune Wellness and HEXO are both very cheap stocks. Canadian investors can buy Neptune for less than $4 per share. Likewise, HEXO sells for less than $2 per share. If you are looking for cheap high-growth stocks to add to your retirement portfolio, these are two excellent choices.
No investment comes without risk, but the beauty in buying cheap stocks is that you buy unlimited potential gains for a small potential loss. Your maximum losses for Neptune Wellness and HEXO stock are less than $400 and $200, respectively.
The post Pot Stock Earnings: 3 Takeaways This Week appeared first on The Motley Fool Canada.
Debra Ray has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.” data-reactid=”50″>Fool contributor Debra Ray has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.
Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2020” data-reactid=”51″>The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2020
Recent Comments